DUSP22 and fatty liver disease: Hepatocyte-specific DUSP22 knockout markedly hastened the development of NASH and HCC in multiple mouse models by facilitating liver steatosis, inflammation, and fibrosis; however, DUSP22 overexpression in hepatocytes dramatically relieved the severe progression of NASH and related HCC in mice.